- About BME
- Academics Home
- Combined Degrees
- Student Resources
- Industry Home
- Partner Benefits
- Student Design Projects
- Guest Lectures
- BME Interns
- Research Collaborations
- Tech Licensing
- Industry News
- "Women's Radio Network Open Forum" To Feature AxoGen, Inc.
- 3rd Annual Pruitt Research Day
- AxoGen, Inc. Announces Clearance from FDA to Proceed with New Multicenter Comparative Study for Avance® Nerve Graft
- AxoGen, Inc. Announces Completion of a Pilot Clinical Study Assessing Cavernous Nerve Reconstruction with Avance® Nerve Graft
- BioD LLC Makes $1 Million Gift Commitment to UF BME
- BioD Receives U.S. Patent for Unique Placental Tissue Technology
- Dr. Peter McFetridge awarded the Tim Brahm Professorship
- Event Celebrates BioD’s $1 Million Gift to BME
- New Industry Partner: Sigma Aldrich Corporation
- RTI Surgical™ Announces Agreement With Novation
- Record BME Industry Partner Participation at the 4th Annual Pruitt Research Day
- SPECIAL EVENT: “Geraldo Rivera Show” to Feature AxoGen, Inc.
- Stryker Provides Guest Lecture to BME Students
- Contact Us
Jon Dobson has been named AAAS Fellow
November 25, 2015
Jon Dobson, a professor at the J. Crayton Pruitt Family Department of Biomedical Engineering, has been named a Fellow of the American Association for the Advancement of Science (AAAS). Dobson will be recognized during a ceremony for new Fellows Saturday, Feb. 13, 2016, during the 2016 AAAS annual meeting in Washington, D.C. The 347 new Fellows from around the globe will be recognized for advancing science or its applications.
He was honored by AAAS for “outstanding contributions to the development of magnetic micro - and nanoparticle-based technologies in cell engineering, regenerative medicine and gene transfection.” Dobson has developed novel technologies for (i) magnetic targeting and remote activation of cell signaling pathways for cell engineering and stem cell therapy; (ii) magnetic nanoparticle-based gene transfection delivery; and (iii) magnetic targeting of modified cell carriers for cancer therapy and regenerative medicine.
“The AAAS’s recognition of Dr. Dobson’s research is extremely well deserved,” said Christine E. Schmidt, Chair of the Department of Biomedical Engineering at UF. “His creativity and energy that he brings to his research and teaching makes an enormous contribution to our growing program in biomedical engineering.”
AAAS, founded in 1848 as a nonprofit association, is the world’s largest scientific society and publisher of the prestigious journal Science as well as Science Translational Medicine and Science Signaling.
Members of AAAS can be considered for recognition as Fellows if they’re nominated by the steering group of an association scientific section, by three Fellows or by the association’s chief executive officer.
Congratulations, Dr. Dobson!